STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
35 hedge funds and large institutions have $385K invested in Statera Biopharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
35
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$13K | |
| 2 | +$11.9K | |
| 3 | +$11.5K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.93K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$921 |
Top Sellers
| 1 | -$36.2K | |
| 2 | -$16.7K | |
| 3 | -$10K | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.35K |